Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 71 of 71 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 07/07/21
End: 12/05/24
Due: 12/05/25
Phase: N/A
Priority: Normal
Start: 04/04/18
End: 02/07/23
Due: 02/07/24
Phase: N/A
Priority: Normal
Start: 02/14/19
End: 10/01/26
Due: 10/01/27
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy Volunteers
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 12/13/21
End: 09/01/28
Due: 09/01/29
Phase: N/A
Priority: Normal
Start: 11/11/24
End: 02/25/26
Due: 02/25/27
Phase: N/A
Priority: Normal
Start: 11/26/19
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 01/27/22
End: 11/01/22
Due: 11/01/23
Phase: N/A
Priority: Normal
Start: 03/08/16
End: 01/23/19
Due: 01/23/20
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 12/18/19
End: 05/24/22
Due: 05/24/23
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 11/30/12
Due: 11/30/13
Phase: N/A
Priority: Normal
Start: 05/29/18
End: 01/15/19
Due: 01/15/20
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 02/22/17
Due: 02/22/18
Phase: N/A
Priority: Normal
Start: 11/05/21
End: 09/13/24
Due: 09/13/25
Phase: N/A
Priority: Normal
Start: 09/19/17
End: 09/12/18
Due: 09/12/19
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 04/26/21
Due: 04/26/22